Tailored surgery according to molecular analysis in differentiated thyroid carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Surgical Oncology

Background:

• Papillary thyroid carcinoma (PTC) is often indolent with good prognosis.
• Conventional staging (TNM) may lead to suboptimal surgical approaches for some PTC cases.
• Molecular testing offers insights into diagnosis and prognosis for differentiated thyroid carcinomas (DTC).

Purpose of the Study:

• To review the implementation of molecular analysis for tailored surgical therapy in differentiated thyroid carcinomas (DTC).
• To explore how molecular testing can improve risk stratification and surgical decision-making in PTC.
• To discuss the role of molecular markers in guiding surgical extent and post-operative management.

Main Methods:

• Review of current literature on molecular testing in differentiated thyroid carcinomas.
• Analysis of how molecular markers influence surgical strategy and patient management.
• Discussion of the integration of molecular data into clinical practice for PTC.

Main Results:

• Molecular testing can refine risk stratification beyond conventional staging for PTC.
• Identifying specific mutations can guide the extent of surgery, potentially avoiding overtreatment.
• Molecular insights can help in simplifying post-operative follow-up, including radioiodine therapy decisions.

Conclusions:

• Molecular analysis is crucial for developing tailored surgical approaches in differentiated thyroid carcinomas.
• Integrating molecular data improves the precision of surgical therapy and patient management for PTC.
• This personalized strategy optimizes treatment and reduces unnecessary interventions in DTC.